Integrative Transcriptomic and Network-Based Analysis of Neuromuscular Diseases

Area of Science:

• Genomics and Bioinformatics
• Systems Biology
• Rare Diseases Research

Background:

• Neuromuscular diseases (NMDs), including Duchenne muscular dystrophy (DMD), limb-girdle muscular dystrophy (LGMD), and amyotrophic lateral sclerosis (ALS), are rare, progressive disorders with complex, often poorly understood molecular underpinnings.
• Traditional transcriptomic analyses face challenges in capturing systemic dysregulation in rare diseases due to small sample sizes and limited scope.

Purpose of the Study:

• To apply an integrative systems biology approach to comprehensively analyze molecular dysregulation in DMD, LGMD, and ALS.
• To identify shared pathways, novel regulatory elements, and potential therapeutic targets across different NMDs.

Main Methods:

• Differential gene expression analysis of eight public RNA-seq datasets from DMD, LGMD, and ALS patient samples.
• Integration of differential expression data with protein-protein interaction (PPI) networks and network embedding techniques.
• Comparative functional enrichment analysis and mapping of differentially expressed genes (DEGs) onto the human PPI network.

Main Results:

• Identified disease-relevant pathways and unexpected enrichments, such as renal development, indicating systemic effects.
• Revealed shared pathways like glycosaminoglycan binding in DMD and FUS-ALS, suggesting extracellular matrix involvement.
• Uncovered dysregulated non-coding RNAs (e.g., PAX8-AS1, SBF2-AS1, NEAT1) and candidate genes (e.g., HS3ST3A1) proximal to causal genes.

Conclusions:

• An integrative systems biology approach enhances the understanding of complex molecular mechanisms in NMDs.
• Shared transcriptional programs and novel targets, including non-coding RNAs and extracellular matrix interactions, were identified across DMD, LGMD, and ALS.
• This research advances understanding and may inform future therapeutic strategies for these rare neuromuscular disorders.